Leadership Giving

Move Healthcare Upstream.

KiCares brings together philanthropy, research, education and collaboration to create more opportunities to understand chronic disease earlier, and more time to act.

For the families, clinicians and scientists working against the clock, earlier knowledge is not a convenience. It is the difference between managing a lifetime of disease and changing its course before it begins.

38M
Americans living with diabetes today
1.2M
new diagnoses each year in the U.S.
1 in 3
Medicare dollars go to diabetes care

Education. Research. Collaboration. Earlier Action.

A multigenerational family talking with a clinician in a bright consultation room

The Imperative

The cost of waiting is measured in lives, time and opportunity.

Too often, chronic disease is recognized only after meaningful biological damage has occurred. Earlier knowledge can create more opportunities to educate, screen, monitor, study and respond.

0%

of global non-pandemic-related deaths were caused by noncommunicable diseases in 2021.

Source: WHO, On the road to 2025
0 million

people worldwide died from noncommunicable diseases in 2021.

Source: WHO, On the road to 2025
0 in 4

American adults have at least one chronic condition, and more than half have two or more.

Source: CDC, About Chronic Diseases
0%
of $5.3 trillion

in annual U.S. healthcare expenditures are for people with chronic and mental health conditions.

Source: CDC, Health and Economic Costs of Chronic Conditions

Why Philanthropy Matters

Breakthroughs need capital willing to move before certainty.

America does not suffer from a lack of healthcare spending. It suffers from a system that still devotes enormous resources to managing chronic disease after it has taken hold.

Earlier understanding, prevention and disease interception require a different kind of investment, flexible, patient and willing to support important ideas before every question has been answered.

0 years

is the average time it takes for research evidence to reach routine clinical practice, a gap flexible philanthropy can help close.

Source: Morris et al, Journal of the Royal Society of Medicine
0 in 10

investigational drugs that enter clinical trials are eventually approved, the valley of death where early philanthropic seed support can make the difference.

Source: Hay et al, Nature Biotechnology
< 0%
of U.S. health spending

goes toward public health and prevention, even as chronic disease drives most of the nation’s healthcare costs.

Source: Trust for America’s Health

We spend trillions managing the consequences of chronic disease. Philanthropy can help fund the work that happens before those consequences become inevitable.

The Funding Gap

Different forms of capital enter at different moments.

Public funding

Essential for scientific infrastructure and research at scale.

Public funding provides indispensable support for science, institutions and established research priorities. However, funding programs commonly operate through defined mandates, formal review processes and multiyear cycles that can make it difficult to move quickly around emerging or unconventional opportunities.

Commercial capital

Powerful when a path to market becomes visible.

Industry and venture investment can accelerate clinical development and commercialization, but generally become more available once intellectual property, clinical utility, regulatory strategy and commercial potential are sufficiently developed.

Philanthropic capital

Able to act earlier and with greater flexibility.

Philanthropy can support high-potential ideas before conventional funding is available. It can connect disciplines, fund preliminary evidence, support public education, convene collaborators and help promising work reach the point where larger institutions can participate.

How early support can catalyze larger change

  1. Unanswered question
  2. Philanthropic seed support
  3. Preliminary evidence
  4. Institutional and public funding
  5. Clinical or community application
  6. Scaled impact

Illustrative progression. Not every project will move through every stage.

Fund what happens before the breakthrough.

The most consequential ideas do not always begin with certainty. They begin with a question, an unmet need and someone willing to provide the first meaningful support.

Leadership donors give KiCares the flexibility to explore promising opportunities, support qualified research, connect the right collaborators and advance work that may otherwise remain unfunded.

Philanthropy does not replace government, universities or industry. It can provide the catalytic support that allows important ideas to become credible programs, stronger evidence and, ultimately, opportunities for broader impact.

Researchers analyzing biological data together in a modern laboratory

The Opportunity

More knowledge. More time. More options.

KiCares believes healthcare can move further upstream, before chronic disease creates irreversible consequences.

By advancing public education, supporting qualified research and connecting healthcare and scientific organizations, KiCares helps create the conditions for earlier biological understanding and more informed action.

We cannot change the course of chronic disease if we only begin responding after the damage is done.

A Defining Chronic-Disease Challenge

The scale of diabetes illustrates the need for a more preventive future.

0.0 million

people in the United States were estimated to have diagnosed or undiagnosed diabetes in 2023.

Source: CDC National Diabetes Statistics Report
0.0 million

U.S. adults were estimated to have prediabetes.

Source: CDC National Diabetes Statistics Report

An illustrative progression

01

Prediabetes

Biological changes are underway and often unrecognized.

02

Diabetes

A diagnosis is made, frequently after damage has begun.

03

Progressive complications

Cardiovascular, kidney, vision and nerve complications may follow.

Diabetes is presented here as one example of the larger chronic-disease challenge. Not every case progresses, and earlier detection does not guarantee prevention.

Our Vision

A future in which earlier understanding leads to better options.

KiCares Research Institute supports education, scientific research and collaboration focused on chronic disease, prevention, screening and earlier detection.

We envision a connected ecosystem in which patients, families, researchers, clinicians, universities and healthcare organizations can advance knowledge together.

KiCares

at the center of a connected ecosystem

  • Patients and families
  • Researchers
  • Clinicians
  • Universities
  • Health systems
  • Philanthropic partners

The Platform for Impact

Philanthropy can accelerate education, research and collaboration.

A health educator speaking with a small group of adults in a bright community room
01

Public Education

Provide credible information about chronic disease, prevention, screening and earlier detection.

Two research scientists reviewing data on a large screen in a modern laboratory
02

Scientific Research

Support qualified research initiatives advancing disease understanding, detection, monitoring and patient care.

Clinicians and academic researchers in discussion around a conference table
03

Healthcare Collaboration

Bring researchers, clinicians, universities and health systems together around shared scientific and public-health priorities.

A community health volunteer greeting neighbors at an outdoor health information table
04

Community Engagement

Connect individuals and families with trustworthy health information and emerging scientific knowledge.

From Generosity to Impact

Leadership giving creates the conditions for earlier action.

  1. 01

    Leadership Giving

  2. 02

    Education, Research and Collaboration

  3. 03

    Greater Knowledge and Scientific Understanding

  4. 04

    More Opportunities for Earlier Action

  5. 05

    Healthier Futures

Leadership gifts provide KiCares with the resources and flexibility to support promising programs, convene the right participants and respond to meaningful opportunities for charitable impact.

Opportunities to Lead

Philanthropy can be catalytic.

  1. 01

    Public education initiatives

  2. 02

    Qualified scientific research

  3. 03

    Early-detection education

  4. 04

    Scientific meetings and collaboration

  5. 05

    Community health engagement

  6. 06

    Unrestricted mission support

Leadership gifts may support a specific initiative, provide flexible funding for the broader mission or help establish a multiyear program aligned with a donor's philanthropic priorities.

Stewardship and Accountability

Trust deserves accountability.

KiCares is committed to responsible stewardship, mission-aligned decision-making and transparent communication with its philanthropic partners.

Learn About Our Governance
01
Responsible financial oversight
02
Careful evaluation of supported programs
03
Appropriate grant documentation and monitoring
04
Meaningful donor reporting and communication

Ways to Partner

Create a giving approach aligned with your philanthropic priorities.

  • Outright leadership gifts
  • Multiyear commitments
  • Donor-advised funds
  • Family and private foundations
  • Corporate and institutional support
  • Gifts of appreciated securities
  • Program sponsorship
  • Secure direct bank transfer

For donor security, KiCares provides bank-transfer and securities instructions directly following confirmation of the donor and intended gift.

An Invitation to Lead

Help create a future with more knowledge, more time and more options.

Leadership donors can help KiCares advance education, strengthen scientific collaboration and expand opportunities for earlier action against chronic disease.

A multi-generational family embracing each other in warm golden-hour light